Immunome, Inc. (IMNM)

21.50 -0.64 (-2.89%) USD  |  NASDAQ  |  Feb 20, 16:00
21.51 +0.01 (+0.05%) After-Hours: 20:00
More

Immunome Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for IMNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Prelude Therapeutics, Inc. Upgrade
Eli Lilly & Co. Upgrade
Relay Therapeutics, Inc. Upgrade
Context Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade